サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1515507

非ウイルス性トランスフェクション試薬およびシステム市場：タイプ別、用途別、エンドユーザー別、：国別、地域別 - 産業分析、市場規模、市場シェア、2024年～2032年の予測

Non-Viral Transfection Reagents and Systems Market, By Type, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 299 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
非ウイルス性トランスフェクション試薬およびシステム市場：タイプ別、用途別、エンドユーザー別、：国別、地域別 - 産業分析、市場規模、市場シェア、2024年～2032年の予測
出版日: 2024年06月04日
発行: AnalystView Market Insights
ページ情報: 英文 299 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

非ウイルス性トランスフェクション試薬およびシステム市場規模は2023年に7億8,623万米ドルとなり、2024年から2032年にかけてCAGR 8.2％で拡大

非ウイルス性トランスフェクション試薬およびシステム市場力学

臨床現場における非ウイルス性トランスフェクション試薬のニーズが市場成長の原動力となっています。

非ウイルス性トランスフェクションは、確立された手法に代わる有力な選択肢であり、明確な利点を提供します。これらの利点には、迅速なタイムライン、生物学的効率の向上、細胞毒性の低減、より多様な核酸を送達する能力などが含まれます。臨床応用における非ウイルス性トランスフェクション試薬の極めて重要な役割は、その成長の主要な原動力です。これらの試薬は、siRNA、miRNA、治療用タンパク質をコードするDNAプラスミドやCRISPR/Cas9ゲノム編集ツールなどの治療用核酸の送達を容易にします。この能力は、遺伝性疾患、がん、感染症など、幅広い疾患に対する革新的な遺伝子治療の開発に道を開くものです。

現在の情勢は、先進的な非ウイルス性トランスフェクション試薬やシステムの開発に積極的な数多くの企業による活動の急増を反映しています。例えば、最近、細胞治療のエキスパートであるBioCentriq社とMITの新興企業であるKytopen社が提携し、革新的な細胞治療製造技術を開発しました。

非ウイルス性トランスフェクション試薬およびシステム市場-主要洞察

調査アナリストの分析によると、世界市場は予測期間（2024-2032年）に約8.2%のCAGRで毎年成長すると予測されています。

タイプ別セグメンテーションでは、非ウイルス性トランスフェクション試薬が2023年に最大市場シェアを示すと予測されています。

用途別では、研究用途が2023年の主要タイプでした。

エンドユーザー別では、製薬会社が2023年の主要タイプでした。

地域別では、アジア太平洋地域が2023年に収益でリードしました。

非ウイルス性トランスフェクション試薬およびシステム市場-セグメンテーション分析：

世界の非ウイルス性トランスフェクション試薬およびシステム市場は、タイプ、アプリケーション、エンドユーザー、地域に基づいてセグメント化されます。

市場はタイプによって3つに分類されます：非ウイルス性トランスフェクション試薬、エレクトロポレーションに基づくトランスフェクションシステム、その他の非ウイルス性トランスフェクションシステム。エレクトロポレーションは、核酸の存在下で細胞に電気パルスを印加し、細胞膜に一時的な孔を形成させ、そこから遺伝物質を侵入させる。エレクトロポレーションはトランスフェクション効率が高いことで知られ、特にトランスフェクションが困難な細胞や初代細胞に有効です。エレクトロポレーションは、一過性のトランスフェクションや安定したトランスフェクションに使用できるが、特殊な装置と異なる細胞種に対する最適化が必要です。

市場は用途によって2つのカテゴリーに分けられる：臨床と調査です。非ウイルス性トランスフェクション試薬に基づく調査は、生物学的および生物医学的分野の広い範囲に及ぶ。例えば遺伝子機能研究では、研究者は非ウイルス性トランスフェクション試薬を用いて特定の遺伝子や制御因子を細胞に導入します。これにより、遺伝子発現パターン、制御機構、様々な細胞プロセスにおける遺伝子の役割を研究することができます。

非ウイルス性トランスフェクション試薬およびシステム市場-地理的洞察

アジア太平洋地域のバイオテクノロジーおよび製薬産業は、研究開発への多額の投資により急速に拡大しています。この成長は、中国、日本、韓国などの国々で特に顕著です。その結果、非ウイルス性トランスフェクション試薬に対するニーズが高まっています。これらの試薬は、標的細胞に遺伝物質を正確に送達し、遺伝子治療や遺伝子編集技術の開発をサポートするために極めて重要です。さらに、遺伝性疾患の有病率の上昇が、この地域の生物医学研究や治療の進歩におけるこれらの試薬の需要の高まりに寄与しています。例えば、パキスタンの人口構成は多様で、近親婚が多いことが特徴であり、遺伝性疾患の有病率の上昇に寄与しています。

非ウイルス性トランスフェクション試薬およびシステム市場-競合情勢：

非ウイルス性トランスフェクション試薬およびシステム市場の主要企業には、サーモフィッシャーサイエンティフィック、バイオ・ラッド・ラボラトリーズ、イノビオ・ファーマシューティカルズ、マックスサイトなどがあります。各社は、遺伝子操作や細胞工学に関わる研究や治療アプリケーションを推進するために、独自の技術や専門知識を提供しています。例えば、MaxCyte社は、初代細胞、幹細胞、細胞株への一過性および安定したトランスフェクションのためのスケーラブルなソリューションを提供しています。MaxCyte社のシステムは、その高いトランスフェクション効率、拡張性、研究・臨床現場での適用性で評価されています。

バイオ・ラッド・ラボラトリーズ社は、エレクトロポレーションに基づくトランスフェクション・システムを専門としており、電気パルスを印加することにより、細胞内に核酸を高効率で導入することができます。バイオ・ラッドのシステムは、研究およびバイオ医薬品アプリケーションにおいて、トランスフェクションが困難な細胞や1次細胞に広く使用されています。

目次

第1章 非ウイルス性トランスフェクション試薬およびシステム市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 非ウイルス性トランスフェクション試薬およびシステムの主な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 非ウイルス性トランスフェクション試薬およびシステム産業研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 非ウイルス性トランスフェクション試薬およびシステム市場：COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 非ウイルス性トランスフェクション試薬およびシステムの市場情勢

  • 非ウイルス性トランスフェクション試薬およびシステムの市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 非ウイルス性トランスフェクション試薬およびシステム市場- タイプ別

  • 概要
    • セグメントシェア分析
    • 非ウイルストランスフェクション試薬
    • エレクトロポレーションベースのトランスフェクションシステム
    • その他の非ウイルス性トランスフェクションシステム

第8章 非ウイルス性トランスフェクション試薬およびシステム市場- 用途別

  • 概要
    • セグメントシェア分析
    • 臨床
    • 調査

第9章 非ウイルス性トランスフェクション試薬およびシステム市場- エンドユーザー別

  • 概要
    • セグメントシェア分析
    • 学術研究
    • 製薬会社
    • その他

第10章 非ウイルス性トランスフェクション試薬およびシステム市場- 地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- 非ウイルス性トランスフェクション試薬およびシステム業界

  • 競争ダッシュボード
  • 企業プロファイル
    • Thermo Fisher Scientific（TFS）
    • Lonza Group
    • Imunon（Formerly known as Celsion）
    • Promega Corporation
    • Altogen Biosystems
    • Mirus Bio LLC
    • Genprex
    • Polyplus-Transfection SA
    • Bio-Rad Laboratories
    • MaxCyte
    • MilliporeSigma
    • Qiagen
    • Takara Bio

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Non-Viral Transfection Reagents and Systems Market: Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Non-Viral Transfection Reagents and Systems Market, by Type 2019-2032 (USD Million)
  • TABLE Non-Viral Transfection Reagents and Systems Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Non-Viral Transfection Reagents and Systems Market, by Application 2019-2032 (USD Million)
  • TABLE Non-Viral Transfection Reagents and Systems Market: End User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Non-Viral Transfection Reagents and Systems Market, by End User 2019-2032 (USD Million)
  • TABLE Non-Viral Transfection Reagents and Systems Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Non-Viral Transfection Reagents and Systems Market, by Region 2019-2032 (USD Million)
  • TABLE North America Non-Viral Transfection Reagents and Systems Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Non-Viral Transfection Reagents and Systems Market, by Type, 2019-2032 (USD Million)
  • TABLE North America Non-Viral Transfection Reagents and Systems Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Non-Viral Transfection Reagents and Systems Market, by End User, 2019-2032 (USD Million)
  • TABLE Europe Non-Viral Transfection Reagents and Systems Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Non-Viral Transfection Reagents and Systems Market, by Type, 2019-2032 (USD Million)
  • TABLE Europe Non-Viral Transfection Reagents and Systems Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Non-Viral Transfection Reagents and Systems Market, by End User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Non-Viral Transfection Reagents and Systems Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Non-Viral Transfection Reagents and Systems Market, by Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Non-Viral Transfection Reagents and Systems Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Non-Viral Transfection Reagents and Systems Market, by End User, 2019-2032 (USD Million)
  • TABLE Latin America Non-Viral Transfection Reagents and Systems Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Non-Viral Transfection Reagents and Systems Market, by Type, 2019-2032 (USD Million)
  • TABLE Latin America Non-Viral Transfection Reagents and Systems Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Non-Viral Transfection Reagents and Systems Market, by End User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Non-Viral Transfection Reagents and Systems Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Non-Viral Transfection Reagents and Systems Market, by Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Non-Viral Transfection Reagents and Systems Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Non-Viral Transfection Reagents and Systems Market, by End User, 2019-2032 (USD Million)

List of Figures

  • FIGURE Non-Viral Transfection Reagents and Systems Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Type segment market share analysis, 2023 & 2032
  • FIGURE Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Application segment market share analysis, 2023 & 2032
  • FIGURE Application segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE End User segment market share analysis, 2023 & 2032
  • FIGURE End User segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Non-Viral Transfection Reagents and Systems Market share and leading players, 2023
  • FIGURE Europe Non-Viral Transfection Reagents and Systems Market share and leading players, 2023
  • FIGURE Asia Pacific Non-Viral Transfection Reagents and Systems Market share and leading players, 2023
  • FIGURE Latin America Non-Viral Transfection Reagents and Systems Market share and leading players, 2023
  • FIGURE Middle East and Africa Non-Viral Transfection Reagents and Systems Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Non-Viral Transfection Reagents and Systems Market share analysis by country, 2023
  • FIGURE Germany Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Non-Viral Transfection Reagents and Systems Market share analysis by country, 2023
  • FIGURE India Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Philippines Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Non-Viral Transfection Reagents and Systems Market share analysis by country, 2023
  • FIGURE Brazil Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Non-Viral Transfection Reagents and Systems Market share analysis by country, 2023
  • FIGURE Saudi Arabia Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
目次
Product Code: ANV3258

REPORT HIGHLIGHT

Non-Viral Transfection Reagents and Systems Market size was valued at USD 786.23 Million in 2023, expanding at a CAGR of 8.2% from 2024 to 2032.

Non-viral transfection reagents are substances used in molecular biology and biotechnology to deliver genetic material (such as DNA or RNA) into cells without the use of viral vectors. They facilitate the introduction of nucleic acids into cells for various purposes, including gene expression studies, protein production, gene therapy, and genome editing.

Non-Viral Transfection Reagents and Systems Market- Market Dynamics

The need for Non-Viral Transfection Reagents in clinical settings is fueling their market growth.

Non-viral transfection is a compelling alternative to established methods, offering distinct advantages. These advantages include expedited timelines, enhanced biological efficiency, reduced cytotoxicity, and the ability to deliver a wider variety of nucleic acids. The pivotal role of non-viral transfection reagents in clinical applications is a key driver of their growth. These reagents facilitate the delivery of therapeutic nucleic acids, such as siRNA, miRNA, and DNA plasmids encoding therapeutic proteins or CRISPR/Cas9 genome editing tools. This capability paves the way for the development of innovative gene therapies for a broad spectrum of conditions, including genetic disorders, cancers, and infectious diseases.

The current landscape reflects a surge in activity by numerous companies actively developing advanced non-viral transfection reagents and systems. For example, recently, BioCentriq, a cell therapy expert, and Kytopen, an MIT startup, teamed up to develop innovative cell therapy manufacturing technology.

Non-Viral Transfection Reagents and Systems Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.2% over the forecast period (2024-2032)

Based on Type segmentation, non-viral transfection reagents were predicted to show maximum market share in the year 2023

Based on Application segmentation, Research Applications was the leading type in 2023

Based on End User segmentation, Pharmaceutical Companies were the leading type in 2023

Based on region, Asia-Pacific was the leading revenue generator in 2023

Non-Viral Transfection Reagents and Systems Market- Segmentation Analysis:

The Global Non-Viral Transfection Reagents and Systems Market is segmented based on Type, Application, End User, and Region.

The market is divided into three categories based on Type: Non-Viral Transfection Reagents, Electroporation-based Transfection Systems and Other Non-Viral Transfection Systems. Electroporation involves applying electrical pulses to cells in the presence of nucleic acids, creating temporary pores in the cell membrane through which genetic material can enter. Electroporation is known for its high transfection efficiency and is particularly effective for difficult-to-transfect cells and primary cells. It can be used for transient and stable transfection but requires specialized equipment and optimization for different cell types.

The market is divided into two categories based on Application: Clinical and Research. Research based on non-viral transfection reagents spans a wide spectrum of biological and biomedical fields. Such as in gene function studies, researchers employ non-viral transfection reagents to introduce specific genes or regulatory elements into cells. This allows them to study gene expression patterns, regulatory mechanisms, and the roles of genes in various cellular processes.

Non-Viral Transfection Reagents and Systems Market- Geographical Insights

The biotechnology and pharmaceutical industries in the Asia-Pacific region are expanding swiftly due to substantial investments in research and development. This growth is particularly pronounced in countries such as China, Japan, and South Korea. As a result, there is an increasing need for non-viral transfection reagents. These reagents are crucial for delivering genetic material precisely to target cells and supporting the development of gene therapy and gene editing technologies. Moreover, the rising prevalence of genetic disorders is contributing to the heightened demand for these reagents in the region's biomedical research and therapeutic advancements. For instance, the diverse makeup of Pakistan's population, characterized by significant levels of consanguinity, contributes to the higher prevalence of genetic disorders cases.

Non-Viral Transfection Reagents and Systems Market- Competitive Landscape:

Some of the key players in the Non-Viral Transfection Reagent and Systems Market are Thermo Fisher Scientific, Bio-Rad Laboratories, Inovio Pharmaceuticals, and MaxCyte. Each brings unique technologies and expertise to advance research and therapeutic applications involving genetic manipulation and cell engineering. For example, MaxCyte, is offering scalable solutions for transient and stable transfection of primary cells, stem cells, and cell lines. MaxCyte's systems are valued for their high transfection efficiency, scalability, and applicability in research and clinical settings.

Bio-Rad Laboratories specialises in electroporation-based transfection systems, which offer high efficiency for delivering nucleic acids into cells by applying electrical pulses. Bio-Rad's systems are widely used for difficult-to-transfect cells and primary cells in research and biopharmaceutical applications.

Recent Developments:

In Sept 2023, A new enterprise stemming from the University of Nottingham, dedicated to advancing a dry powder gene therapy formulation for bone graft augmentation, along with its partner, the University of Nottingham, has been granted £995,000 by Innovate UK, the UK's innovation agency.

In August 2023, Altogen Biosystems introduced a focused reagent designed to transport biomolecules to the lungs for treating patients with pulmonary diseases. The drug has safely and effectively transported small molecules, DNA, RNA, and proteins to the lungs.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NON-VIRAL TRANSFECTION REAGENTS AND SYSTEMS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Thermo Fisher Scientific (TFS)

Lonza Group

Imunon (Formerly known as Celsion)

Promega Corporation

Altogen Biosystems

Mirus Bio LLC

Genprex

Polyplus-Transfection SA

Bio-Rad Laboratories

MaxCyte

MilliporeSigma

Qiagen

Takara Bio

GLOBAL NON-VIRAL TRANSFECTION REAGENTS AND SYSTEMS MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Non-Viral Transfection Reagents
  • Electroporation-based Transfection Systems
  • Other Non-Viral Transfection Systems

GLOBAL NON-VIRAL TRANSFECTION REAGENTS AND SYSTEMS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Clinical
  • Research

GLOBAL NON-VIRAL TRANSFECTION REAGENTS AND SYSTEMS MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Academic and Research
  • Pharmaceutical Companies
  • Others

GLOBAL NON-VIRAL TRANSFECTION REAGENTS AND SYSTEMS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Non-Viral Transfection Reagents and Systems Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Non-Viral Transfection Reagents and Systems Market Snippet by Type
    • 2.1.2. Non-Viral Transfection Reagents and Systems Market Snippet by Application
    • 2.1.3. Non-Viral Transfection Reagents and Systems Market Snippet by End User
    • 2.1.4. Non-Viral Transfection Reagents and Systems Market Snippet by Country
    • 2.1.5. Non-Viral Transfection Reagents and Systems Market Snippet by Region
  • 2.2. Competitive Insights

3. Non-Viral Transfection Reagents and Systems Key Market Trends

  • 3.1. Non-Viral Transfection Reagents and Systems Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Non-Viral Transfection Reagents and Systems Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Non-Viral Transfection Reagents and Systems Market Opportunities
  • 3.4. Non-Viral Transfection Reagents and Systems Market Future Trends

4. Non-Viral Transfection Reagents and Systems Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Non-Viral Transfection Reagents and Systems Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Non-Viral Transfection Reagents and Systems Market Landscape

  • 6.1. Non-Viral Transfection Reagents and Systems Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Non-Viral Transfection Reagents and Systems Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2. Non-Viral Transfection Reagents
    • 7.1.3. Electroporation-based Transfection Systems
    • 7.1.4. Other Non-Viral Transfection Systems

8. Non-Viral Transfection Reagents and Systems Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. Clinical
    • 8.1.3. Research

9. Non-Viral Transfection Reagents and Systems Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 9.1.2. Academic and Research
    • 9.1.3. Pharmaceutical Companies
    • 9.1.4. Others

10. Non-Viral Transfection Reagents and Systems Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Non-Viral Transfection Reagents and Systems Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Non-Viral Transfection Reagents and Systems Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Non-Viral Transfection Reagents and Systems Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Non-Viral Transfection Reagents and Systems Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Non-Viral Transfection Reagents and Systems Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Non-Viral Transfection Reagents and Systems Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Thermo Fisher Scientific (TFS)
    • 11.2.2. Lonza Group
    • 11.2.3. Imunon (Formerly known as Celsion)
    • 11.2.4. Promega Corporation
    • 11.2.5. Altogen Biosystems
    • 11.2.6. Mirus Bio LLC
    • 11.2.7. Genprex
    • 11.2.8. Polyplus-Transfection SA
    • 11.2.9. Bio-Rad Laboratories
    • 11.2.10. MaxCyte
    • 11.2.11. MilliporeSigma
    • 11.2.12. Qiagen
    • 11.2.13. Takara Bio

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us